Yingxu Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yingxu Ma has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Jiayi Zhu
Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha City, China
2 shared publicationsJiayue Duan
Department of Endocrinology, Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Ministry of Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
2 shared publicationsQiuzhen Lin
Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha City, China
2 shared publicationsTao Tu
Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha City, China
2 shared publicationsYunying Huang
Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha City, China
2 shared publicationsFanqi Li
Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha City, China
1 shared publication
Latest Publications
- 8 May 2025
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 276 (2) , 625-635
Separating the effects of childhood and adult obesity on depression, subjective well-being, and suicide attempt: a Mendelian randomization study
Observational studies have linked obesity, both in childhood and adulthood, with higher risks of depression, reduced subjective well-being (SWB), and suicide attempts (SA). However, the causality remains unclear. This study aimed to investigate the causal effects of childhood and adult obesity on depression, SWB, and SA. A bidirectional two-sample Mendelian randomization (MR) was performed using genome-wide association study (GWAS) data to examine the causal effects of body mass index (BMI) on depression, SWB, and SA. The inverse variance weighted method was used for primary analysis. Univariable and multivariable MR were employed to assess the total and independent effects of early life and adult body size. Cochran’s Q test and MR-Egger intercept were applied to evaluate heterogeneity and pleiotropy. Genetically predicted BMI was significantly associated with an increased risk of major depressive disorder (MDD: OR = 1.13, 95%CI = 1.06–1.22, p = 6.1 × 10⁻⁴), SA-ISGC (OR = 1.17, 95%CI = 1.08–1.27, p = 1.9 × 10⁻⁴), and SA-iPSYCH (OR = 1.31, 95%CI = 1.12–1.54, p = 6.2 × 10⁻⁴). No significant causal effects of MDD, SWB, or SA on BMI were found. Early-life body size showed no direct effect on MDD or SA. However, adult body size was directly linked to increased risks of MDD (OR = 1.32, 95%CI = 1.13–1.55, p = 4.7 × 10⁻⁴), SA-ISGC (OR = 1.24, 95%CI = 1.03–1.47, p = 0.022), and SA-iPSYCH (OR = 1.80, 95%CI = 1.29–2.50, p = 5.6 × 10⁻⁴). This study provides robust evidence supporting a causal link between obesity and an increased risk of both depression and SA, with adult body size exerting a more direct impact on these outcomes than early-life body size.
- 8 May 2025
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 276 (2) , 625-635
Separating the effects of childhood and adult obesity on depression, subjective well-being, and suicide attempt: a Mendelian randomization study
Observational studies have linked obesity, both in childhood and adulthood, with higher risks of depression, reduced subjective well-being (SWB), and suicide attempts (SA). However, the causality remains unclear. This study aimed to investigate the causal effects of childhood and adult obesity on depression, SWB, and SA. A bidirectional two-sample Mendelian randomization (MR) was performed using genome-wide association study (GWAS) data to examine the causal effects of body mass index (BMI) on depression, SWB, and SA. The inverse variance weighted method was used for primary analysis. Univariable and multivariable MR were employed to assess the total and independent effects of early life and adult body size. Cochran’s Q test and MR-Egger intercept were applied to evaluate heterogeneity and pleiotropy. Genetically predicted BMI was significantly associated with an increased risk of major depressive disorder (MDD: OR = 1.13, 95%CI = 1.06–1.22, p = 6.1 × 10⁻⁴), SA-ISGC (OR = 1.17, 95%CI = 1.08–1.27, p = 1.9 × 10⁻⁴), and SA-iPSYCH (OR = 1.31, 95%CI = 1.12–1.54, p = 6.2 × 10⁻⁴). No significant causal effects of MDD, SWB, or SA on BMI were found. Early-life body size showed no direct effect on MDD or SA. However, adult body size was directly linked to increased risks of MDD (OR = 1.32, 95%CI = 1.13–1.55, p = 4.7 × 10⁻⁴), SA-ISGC (OR = 1.24, 95%CI = 1.03–1.47, p = 0.022), and SA-iPSYCH (OR = 1.80, 95%CI = 1.29–2.50, p = 5.6 × 10⁻⁴). This study provides robust evidence supporting a causal link between obesity and an increased risk of both depression and SA, with adult body size exerting a more direct impact on these outcomes than early-life body size.
- Open Access
- 3 February 2025
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 11 (2) , e28
Casual associations between frailty and nine mental disorders: bidirectional Mendelian randomisation study
Background: An increasing number of observational studies have reported associations between frailty and mental disorders, but the causality remains ambiguous. Aims: To assess the bidirectional causal relationship between frailty and nine mental disorders. Method: We conducted a bidirectional two-sample Mendelian randomisation on genome-wide association study summary data, to investigate causality between frailty and nine mental disorders. Causal effects were primarily estimated using inverse variance weighted method. Several secondary analyses were applied to verify the results. Cochran's Q-test and Mendelian randomisation Egger intercept were applied to evaluate heterogeneity and pleiotropy. Results: Genetically determined frailty was significantly associated with increased risk of major depressive disorder (MDD) (odds ratio 1.86, 95% CI 1.36–2.53, P = 8.1 × 10−5), anxiety (odds ratio 2.76, 95% CI 1.56–4.90, P = 5.0 × 10−4), post-traumatic stress disorder (PTSD) (odds ratio 2.56, 95% CI 1.69–3.87, P = 9.9 × 10−6), neuroticism (β = 0.25, 95% CI 0.11–0.38, P = 3.3 × 10−4) and insomnia (β = 0.50, 95% CI 0.25–0.75, P = 1.1 × 10−4). Conversely, genetic liability to MDD, neuroticism, insomnia and suicide attempt significantly increased risk of frailty (MDD: β = 0.071, 95% CI 0.033–0.110, P = 2.8 × 10−4; neuroticism: β = 0.269, 95% CI 0.173–0.365, P = 3.4 × 10−8; insomnia: β = 0.160, 95% CI 0.141–0.179, P = 3.2 × 10−61; suicide attempt: β = 0.056, 95% CI 0.029–0.084, P = 3.4 × 10−5). There was a suggestive detrimental association of frailty on suicide attempt and an inverse relationship of subjective well-being on frailty. Conclusions: Our findings show bidirectional causal associations between frailty and MDD, insomnia and neuroticism. Additionally, higher frailty levels are associated with anxiety and PTSD, and suicide attempts are correlated with increased frailty. Understanding these associations is crucial for the effective management of frailty and improvement of mental disorders.
- 3 February 2025
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 11 (2) , e28
Open AccessCasual associations between frailty and nine mental disorders: bidirectional Mendelian randomisation study
Background: An increasing number of observational studies have reported associations between frailty and mental disorders, but the causality remains ambiguous. Aims: To assess the bidirectional causal relationship between frailty and nine mental disorders. Method: We conducted a bidirectional two-sample Mendelian randomisation on genome-wide association study summary data, to investigate causality between frailty and nine mental disorders. Causal effects were primarily estimated using inverse variance weighted method. Several secondary analyses were applied to verify the results. Cochran's Q-test and Mendelian randomisation Egger intercept were applied to evaluate heterogeneity and pleiotropy. Results: Genetically determined frailty was significantly associated with increased risk of major depressive disorder (MDD) (odds ratio 1.86, 95% CI 1.36–2.53, P = 8.1 × 10−5), anxiety (odds ratio 2.76, 95% CI 1.56–4.90, P = 5.0 × 10−4), post-traumatic stress disorder (PTSD) (odds ratio 2.56, 95% CI 1.69–3.87, P = 9.9 × 10−6), neuroticism (β = 0.25, 95% CI 0.11–0.38, P = 3.3 × 10−4) and insomnia (β = 0.50, 95% CI 0.25–0.75, P = 1.1 × 10−4). Conversely, genetic liability to MDD, neuroticism, insomnia and suicide attempt significantly increased risk of frailty (MDD: β = 0.071, 95% CI 0.033–0.110, P = 2.8 × 10−4; neuroticism: β = 0.269, 95% CI 0.173–0.365, P = 3.4 × 10−8; insomnia: β = 0.160, 95% CI 0.141–0.179, P = 3.2 × 10−61; suicide attempt: β = 0.056, 95% CI 0.029–0.084, P = 3.4 × 10−5). There was a suggestive detrimental association of frailty on suicide attempt and an inverse relationship of subjective well-being on frailty. Conclusions: Our findings show bidirectional causal associations between frailty and MDD, insomnia and neuroticism. Additionally, higher frailty levels are associated with anxiety and PTSD, and suicide attempts are correlated with increased frailty. Understanding these associations is crucial for the effective management of frailty and improvement of mental disorders.